Vor Biopharma (NYSE:VOR) Given “Outperform” Rating at Wedbush
Vor Biopharma (NYSE:VOR – Get Free Report)‘s stock had its “outperform” rating restated by analysts at Wedbush in a report released on Thursday, MarketBeat Ratings reports. VOR has been the subject of several other research reports. Oppenheimer reaffirmed an “outperform” rating and set a $8.00 price objective on shares of Vor Biopharma in a research […]
Vor Biopharma (NYSE:VOR – Get Free Report)‘s stock had its “outperform” rating restated by analysts at Wedbush in a report released on Thursday, MarketBeat Ratings reports. VOR has been the subject of several other research reports. Oppenheimer reaffirmed an “outperform” rating and set a $8.00 price objective on shares of Vor Biopharma in a research […]
